From August 21, 2023 to November 24, 2023, the company has repurchased 618,077 shares, representing 0.15% for CNY 20.01 million. With this, the company has completed the repurchase of 618,077 shares, representing 0.15% for CNY 20.01 million under the buyback announced on August 22, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
19.9 CNY | -3.40% |
|
-6.88% | -37.85% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.85% | 1.13B | |
+52.70% | 796B | |
+41.58% | 628B | |
-4.86% | 358B | |
+21.96% | 331B | |
+11.47% | 301B | |
+17.72% | 244B | |
+4.46% | 228B | |
+13.13% | 214B | |
+10.46% | 165B |
- Stock Market
- Equities
- 688105 Stock
- News Nanjing Vazyme Biotech Co.,Ltd
- Tranche Update on Nanjing Vazyme Biotech Co.,Ltd's Equity Buyback Plan announced on August 22, 2023.